Table 1.

MDS patient characteristics and hematopoietic colony data after LY-215 treatment

S. No.Age/sexWBC, 103/mLHemoglobin, g/dLPlatelet, 103/mLSubtypeCytogeneticsColonies (BFU-E)Pretreatment (CFU-GM)Colonies BFU-Epost–LY treatment CFU-GM
168/M4.59118RCMD+817114932
279/F4.4871RCMDNml39815
354/F2.78.420RCMDNml73166
459/M7.87.713RCMD20q−25305
569/F318.8411RANml85389
670/F2.88533RA5q−431411
785/F2.39.64RCMD20q−69538
878/M4.68.5325RANml1582415
984/M3.511110RA20q−, +81272322
1049/M3.411.575RCMDNml1081916